City
Epaper

How Cyberknife surgery is revolutionising tumour treatment in India

By IANS | Updated: March 6, 2024 16:30 IST

New Delhi, March 6 Cyberknife radiosurgery is a non-invasive, pain-free procedure that eliminates the risks associated with conventional ...

Open in App

New Delhi, March 6 Cyberknife radiosurgery is a non-invasive, pain-free procedure that eliminates the risks associated with conventional surgery and has transformed radiation treatment in oncology, said doctors here on Wednesday.

The non-invasive robotic radiosurgery system enables highly precise and targeted delivery of radiation to tumours, minimising damage to surrounding healthy tissues.

“Cyberknife radiosurgery stands at the forefront of medical innovation, offering a beacon of hope for patients with conditions previously deemed challenging to treat.

“Cyberknife radiosurgery has transformed the landscape of cancer treatment, offering a ray of hope to those battling complex conditions,” he added. Artemis has become the first hospital in India to surpass 1,500 Cyberknife Radio Surgeries.

The utilisation of Cyberknife technology, especially in India, has been limited despite its significant advantages. Depending on the type, size, location of the tumour, a patient must be carefully chosen for better and enhanced outcomes.

“CyberKnife has ability to deliver radiation in shorter time (fewer sessions) with submillimeter accuracy and its continuous imaging (real-time imaging) ensures that the radiation is precisely directed to the tumour, even if the patient moves or if there are slight changes in the tumour position due to breathing or other bodily processes. It is effective in treating a variety of tumours, including those in the brain, spine, lung, liver, and pancreas. Its versatility makes it a valuable tool in the treatment arsenal for many types of tumour. CyberKnife represents a transformative leap in radiation treatment, offering unparalleled precision, adaptability, and reduced invasiveness,” Dr Anita Malik, Radiation Oncologist at Fortis Noida.

“Cyberknife focuses on cancer cells exclusively thus minimising damage to surrounding healthy tissue. Its role in cancer treatment includes treating tumours in various locations, especially those considered challenging or inaccessible by traditional surgery. The Cyberknife's accuracy helps patients with brain, lung, bone, liver tumours etc. as it spares healthy tissues and reduces the side effects for patients,” Dr Shyam Aggarwal, Chairman, Department of Medical Oncology, Sir Ganga Ram Hospital, told IANS.

Dr. Aditya noted that the most noteworthy applications of Cyberknife has been in the treatment of metastatic cancers in the brain.

“Patients who might otherwise have been subjected to whole brain radiation therapy (WBRT), with its attendant risks and side effects, can receive focused Cyberknife radiation therapy. This is particularly beneficial for treating repeated lesions, a scenario where WBRT is not viable due to the risk of exceeding the brain's tolerance for radiation,” he said.

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Open in App

Related Stories

NationalIndia to conduct mock drill across 244 places today

NationalOne arrested from Assam's Barpeta for 'pro-Pak stand'

CricketMI vs GT, IPL 2025: Rain Stops Play Again, Gujarat Titans 4 Runs Behind DLS Par Score; Check Mumbai Weather Update

EntertainmentPurpose is to promote tourism: Telangana Minister Jupally Krishna Rao on organising 72nd Miss World in Hyderabad

NationalAssam: Five Bangladeshi citizens apprehended for illegal infiltration

Technology Realted Stories

TechnologyIndia at the forefront of global energy transition: Piyush Goyal

TechnologyIndia’s 1st human spaceflight scheduled for first quarter of 2027: Minister

TechnologyPaytm Q4 revenue falls 15.7 pc, net loss widens to Rs 544.6 crore QoQ

TechnologyHPCL clocks 18 pc jump in Q4 net profit at Rs 3,355 crore, declares Rs 10.50 dividend

TechnologyGAIL hikes startup investment fund to Rs 500 crore in FY25: Hardeep Puri